- €14.15bn
- €35.11bn
- €46.87bn
- 44
- 97
- 60
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26,901 | 22,580 | 30,620 | 40,335 | 46,872 |
Cost of Revenue | |||||
Gross Profit | 5,283 | 3,459 | 5,537 | 6,853 | 9,240 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24,950 | 22,499 | 30,227 | 38,771 | 43,109 |
Operating Profit | 1,951 | 81 | 393 | 1,564 | 3,763 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,965 | -34 | 648 | 1,560 | 3,253 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,564 | -122 | 470 | 1,141 | 2,451 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,519 | -100 | 457 | 1,141 | 2,451 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,518 | -100 | 457 | 1,141 | 2,451 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.99 | 0.135 | 2.53 | 3.99 | 5.85 |
Dividends per Share |